Titlebook: Cell Biology and Translational Medicine, Volume 10; Stem Cells in Tissue Kursad Turksen Book 2020 The Editor(s) (if applicable) and The Aut

只看該作者 · 發(fā)表于 2025-3-25 20:27:33

COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not,OVID-19 pandemic on January 30, 2020. At this time there is no particular therapy, drug or vaccine available to deal with COVID-19. Today actual data indicates that about 17% of closed COVID-19 cases died. Health care professionals, ministry of health in countries and the public are trying to read t

只看該作者 · 發(fā)表于 2025-3-26 00:26:53

只看該作者 · 發(fā)表于 2025-3-26 06:33:29

只看該作者 · 發(fā)表于 2025-3-26 10:06:53

COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not,nia in severe cases. Mesenchymal stem cells are immunomodulatory and they have regenerative capacity. In this sense, mesenchymal stem cells may improve the patient’s clinical and immunological response to COVID-19.

只看該作者 · 發(fā)表于 2025-3-26 13:35:53

只看該作者 · 發(fā)表于 2025-3-26 19:09:31

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-31 06:54
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved